Publications
- Certolizumab pegol plus MTX administered every 4 weeks is effective in patients with RA who are partial responders to MTX2012 | First Faculty of Medicine
- Metastasis-inducing S100A4 protein is associated with the disease activity of rheumatoid arthritis.2009 | First Faculty of Medicine
- Golimumab in patients with active rheumtoid arhritis and insufficient response to methotrexate.2008 | First Faculty of Medicine
- Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years2024 | First Faculty of Medicine
- Circulating miRNAs in hand osteoarthritis2023 | Faculty of Physical Education and Sport, First Faculty of Medicine
- New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis2023 | First Faculty of Medicine, Second Faculty of Medicine
- Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study2023 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Cardiovascular risk in myositis patients compared with the general population2023 | Faculty of Physical Education and Sport, First Faculty of Medicine
- S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin2023 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Validation of the Czech Version of the Symptoms in Persons at Risk of rheumatoid Arthritis (SPARRA) Questionnaire2023 | Faculty of Physical Education and Sport, First Faculty of Medicine
Loading network view...